| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 695 | 721 | 998 | 1.218 | 8.831 | 1.823 | 3.020 | 5.064 | 4.742 | 5.626 |
| Total Income - EUR | 695 | 721 | 998 | 1.218 | 8.831 | 1.823 | 3.020 | 5.064 | 4.742 | 5.626 |
| Total Expenses - EUR | 507 | 478 | 690 | 466 | 8.565 | 1.549 | 2.092 | 3.925 | 4.230 | 5.628 |
| Gross Profit/Loss - EUR | 188 | 243 | 308 | 753 | 267 | 275 | 928 | 1.140 | 512 | -3 |
| Net Profit/Loss - EUR | 165 | 222 | 278 | 716 | 27 | 220 | 838 | 988 | 430 | -3 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Valy Drugă S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.984 | 1.964 | 1.930 | 1.895 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 9.418 | 9.543 | 9.769 | 10.736 | 4.223 | 4.335 | 5.124 | 6.127 | 8.475 | 6.453 |
| Inventories | 6.571 | 6.738 | 7.021 | 7.836 | 2.217 | 2.522 | 1.566 | 2.959 | 6.020 | 4.488 |
| Receivables | 2.741 | 2.763 | 2.711 | 2.689 | 1.638 | 1.593 | 1.558 | 1.547 | 1.599 | 1.810 |
| Cash | 106 | 42 | 38 | 211 | 368 | 220 | 2.000 | 1.621 | 856 | 155 |
| Shareholders Funds | -10.472 | -10.144 | -9.694 | -8.800 | -8.603 | -8.220 | -7.200 | -6.234 | -5.785 | -5.755 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 21.874 | 21.651 | 21.394 | 21.431 | 12.826 | 12.555 | 12.324 | 12.361 | 14.260 | 12.209 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Valy Drugă S.r.l.